ArborMetrix, Inc.

ArborMetrix, Inc. is a healthcare technology company that focuses on quality improvement by leveraging data analytics for enhancing clinical and financial performance across healthcare organizations. Founded in 2011 in Ann Arbor, US, ArborMetrix, Inc. specializes in healthcare analytics.

The company was established by Justin Dimick and has conducted a total of 7 deals, with the most recent deal taking place on October 18, 2019. In this round, ArborMetrix raised USD 1. 618 mn in venture funding, which represents the total amount raised to date. The current CEO team includes Jeff Pagnini, Kurt Skifstad, and Maria Siambekos.

ArborMetrix specializes in healthcare quality improvement through its advanced technology platform, which delivers actionable insights for clinical and financial performance enhancement. Their core offerings include AMxEngage and AMxEquity, which empower healthcare providers by integrating large datasets, facilitating real-time interventions, and supporting evidence-based clinical decisions. The solutions are designed to address various healthcare challenges, such as reducing post-surgical mortality and improving patient outcomes, by providing a central source of reliable data that enables clinicians and stakeholders to identify drivers of variation and outcomes effectively. ArborMetrix serves a diverse client base that includes healthcare providers, payers, research institutions, and government entities, primarily targeting markets in the United States, where there is an increasing demand for data-driven strategies in healthcare management.

ArborMetrix generates revenue through subscription-based models that provide access to its software solutions, enabling clients to harness the power of data analytics for quality improvement initiatives. Transactions typically involve annual licensing agreements, where healthcare organizations subscribe to utilize the platform’s capabilities for tracking performance metrics and improving patient care. The company's flagship products, such as AMxEngage, offer customizable analytics tools that cater to the specific needs of healthcare providers and payers. Revenue is also bolstered through partnerships with various stakeholders in the healthcare ecosystem, facilitating collaborative efforts aimed at enhancing clinical outcomes and operational efficiency.

The comprehensive nature of these services positions ArborMetrix as a vital partner for organizations seeking to optimize healthcare delivery through data-driven insights. In October 2019, ArborMetrix, Inc. raised USD 1. 618 mn in venture funding, which will be utilized to support the development of new products and further expansion into new markets.

The company is designing upcoming features for its AMxEngage platform aimed at enhancing usability and functionality, with planned releases in the next 12-18 months. Additionally, ArborMetrix is targeting expansion into international markets, particularly in Europe and Asia, by 2022, to capitalize on the growing demand for healthcare analytics solutions globally.